Chemours
449 hedge funds and large institutions have $4.31B invested in Chemours in 2021 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 119 increasing their positions, 133 reducing their positions, and 57 closing their positions.
33% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 57
25% more capital invested
Capital invested by funds: $3.44B → $4.31B (+$869M)
16% more call options, than puts
Call options by funds: $50.5M | Put options by funds: $43.4M
4% more funds holding
Funds holding: 431 → 449 (+18)
0.11% more ownership
Funds ownership: 74.98% → 75.08% (+0.11%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
11% less repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 133
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$41.2M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$35.4M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$30.4M |
| 4 |
Morgan Stanley
New York
|
+$19.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$41.7M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$28.2M |
| 3 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$18.8M |
| 4 |
DnB Asset Management
Oslo,
Norway
|
-$14.2M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$14M |
CC Hedge Fund Activity: Q2 2021 in Review
449 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q2 2021, worth a combined $4.31B — up 25% from $3.44B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new CC positions and 57 closed out — a net gain of 19 holders — while 119 added to existing stakes and 133 trimmed.
The largest buyer was American Century Companies, adding an estimated $41.2M. The largest seller was Arrowstreet Capital, exiting entirely with an estimated $41.7M sold.
- 449 institutional investors held Chemours (CC) as of Q2 2021, up from 431 in Q1 2021.
- Funds reported $4.31B of Chemours stock for Q2 2021, up 25% quarter-over-quarter.
- 76 funds opened new Chemours positions in Q2 2021 and 57 closed out, a net change of +19 holders.
- The largest Chemours buyer in Q2 2021 was American Century Companies, an estimated $41.2M added.
- The largest Chemours seller in Q2 2021 was Arrowstreet Capital, an estimated $41.7M sold.
Based on aggregated 13F filings for Q2 2021.